Columbia Wanger Asset Management’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
SGA
EIP
Columbia Wanger Asset Management's CLB Position: Q4 2017 in Review
Columbia Wanger Asset Management increased its Core Laboratories (CLB) stake by 11% in Q4 2017, buying an estimated $872K and bringing the position to 87,833 shares worth $9.62M. The position accounts for 0.14% of the portfolio, ranked #182.
Columbia Wanger Asset Management first reported a position in CLB in Q2 2013 and has held it in 19 quarters since. The position peaked at $141M in Q1 2014. 356 funds tracked by Wall St. Rank hold CLB as of Q4 2017.
- Columbia Wanger Asset Management held 87,833 shares of Core Laboratories worth $9.62M as of Q4 2017.
- Columbia Wanger Asset Management bought 8,734 Core Laboratories shares in Q4 2017, an estimated $872K.
- Core Laboratories made up 0.14% of Columbia Wanger Asset Management's portfolio in Q4 2017, its #182 holding.
- Columbia Wanger Asset Management first reported a position in Core Laboratories in Q2 2013 and has held it in 19 quarters since.
- Columbia Wanger Asset Management's Core Laboratories position peaked at $141M in Q1 2014.
- 356 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2017.
Based on Columbia Wanger Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.